Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
The US Food and Drug Administration (FDA) recently provided a draft guidance on the application of artificial intelligence (AI) in regulatory decision making. By championing a balance between innovation and safety, this initiative highlights the significance of AI while upholding its rigorous scientific and regulatory standards. Entitled ‘Co...
The clinical trials landscape in 2025 is shaped by technological advancements, regulatory shifts, and a growing demand for innovative therapies. In our latest blog we explore key developments that are poised to leave a lasting impact on clinical trials. 1. AI and Machine Learning: Moving from Hype to Practical Applications Artificial Intelligence (...
Navitas Life Sciences has been at the forefront, sharing knowledge and driving impactful discussions. Here’s a roundup of our top 10 blogs for 2024 that captivated readers and enriched the life sciences community. 1. The Impact of Generative AI in Clinical Trials Generative AI, a specialized branch of Artificial Intelligence (AI), offers tra...
In a recent episode of The Gens & Associates Podcast, host Steve Gens engaged in a compelling discussion with Navitas Life Sciences' leaders: Marty Boom, Global Head of Regulatory & Safety, and Tris Nockles, Labeling Networks Lead. The conversation explored Navitas' innovative "nets" framework, the integration of AI and automation in regula...
As a leading CRO, Navitas Life Sciences consistently drives innovation in clinical trials, including oncology research, data sciences, regulatory affairs and pharmacovigilance. Our thought leaders have published a series of impactful articles that address critical industry challenges and advancements, showcasing our expertise and commitment to impr...
Thailand’s pharmaceutical and clinical trials industry is undergoing a transformative phase, positioning itself as a critical player in the global healthcare ecosystem. As the demand for innovative solutions grows, regulatory complexities, market dynamics, and therapeutic advancements converge to create a challenging yet promising environmen...
As a trusted diabetes CRO, we’re honoured to recognize World Diabetes Day and this year’s theme, 'Breaking Barriers and Bridging Gaps.' This theme calls on us to confront the critical challenges and inequalities that prevent effective diabetes care. Millions around the world struggle to access the healthcare, education, and resources ...
In a world where healthcare increasingly relies on data-driven insights, real-world evidence consulting (RWE) consulting is emerging as a pivotal tool, particularly in the pharmaceutical industry. RWE provides insights into the broader impact of medical interventions beyond the controlled environment of traditional clinical trials. Real world data ...
October is Breast Cancer Awareness Month, an annual campaign dedicated to raising awareness and reflecting on the progress in breast cancer research, prevention, and treatment. Breast cancer remains the most common cancer worldwide, with approximately 2.3 million new cases diagnosed each year. Advances in early detection and treatment are transform...
Decentralized clinical trials (DCTs) and virtual clinical trials helped bring in agility in the clinical trial industry. With innovations such as wearables, remote monitoring devices, and digital platforms, the barriers of geography and access to trial sites are disappearing. As one of the best decentralized clinical trial vendors in the United Sta...